
TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650221406
DO  - doi:10.1002/jbmr.5650221406
SP  - s202
EP  - s251
PY  - 2007
ER  - 

TY  - JOUR
TI  - Program of the 88th Annual Meeting of the American Association of Physical Anthropologists
JO  - American Journal of Physical Anthropology
JA  - Am J Phys Anthropol
VL  - 168
IS  - S68
SN  - 0002-9483
UR  - https://doi.org/10.1002/ajpa.23802
DO  - doi:10.1002/ajpa.23802
SP  - 1
EP  - 283
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Presentation
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 26
IS  - S2
SN  - 0919-8172
UR  - https://doi.org/10.1111/iju.14061
DO  - doi:10.1111/iju.14061
SP  - 5
EP  - 101
PY  - 2019
ER  - 

TY  - JOUR
AU  - Towne, Chris
AU  - Thompson, Kimberly R.
TI  - Overview on Research and Clinical Applications of Optogenetics
JO  - Current Protocols in Pharmacology
JA  - Current Protocols in Pharmacology
VL  - 75
IS  - 1
SN  - 1934-8282
UR  - https://doi.org/10.1002/cpph.13
DO  - doi:10.1002/cpph.13
SP  - 11.19.1
EP  - 11.19.21
KW  - drug discovery
KW  - gene therapy
KW  - neuroscience
KW  - optogenetics
PY  - 2016
AB  - Abstract Optogenetics is a method that uses light to control cells in living tissue, typically neurons, that have been modified to express light-sensitive ion channels and pumps. The approach facilitates neuromodulation in brain preparations and freely moving animals with unmatched spatial and temporal resolution. This optogenetics overview describes the vast array of light-sensitive proteins available and the methods used to deliver them to tissue and modulate them with light. How these methods have so far enhanced our knowledge of fundamental neuroscience and psychiatric disease will be discussed as well as how they may contribute to drug discovery in the future. Finally, the potential rewards and risks of therapeutic gene transfer of optogenetic proteins in humans will be considered. ? 2016 by John Wiley & Sons, Inc.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Clinical & Experimental Ophthalmology
JA  - Clin Experiment Ophthalmol
VL  - 47
IS  - S1
SN  - 1442-6404
UR  - https://doi.org/10.1111/ceo.13632
DO  - doi:10.1111/ceo.13632
SP  - 82
EP  - 164
PY  - 2019
ER  - 

TY  - JOUR
TI  - The Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S5
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7299
DO  - doi:10.1002/bjs.7299
SP  - 1
EP  - 58
PY  - 2010
AB  - Abstract The Annual Scientific Meeting of the Association of Upper Gastrointestinal Surgeons for Great Britain and Ireland takes place this year in Oxford on the 9th and 10th of September. Copyright ? 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

C7  - pp. 315-329
TI  - Index
SN  - 9781118689745
UR  - https://doi.org/10.1002/9781118689691.index
DO  - doi:10.1002/9781118689691.index
SP  - 315-329
PY  - 2010
ER  - 

TY  - JOUR
TI  - AUGIS abstracts 2013
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 100
IS  - s8
SN  - 9781118689745
UR  - https://doi.org/10.1002/bjs.9290
DO  - doi:10.1002/bjs.9290
SP  - 1
EP  - 62
PY  - 2013
ER  - 

TY  - JOUR
TI  - Symposia
JO  - Early Intervention in Psychiatry
JA  - Early Intervention in Psychiatry
VL  - 10
IS  - S1
SN  - 9781118689745
UR  - https://doi.org/10.1111/eip.12395
DO  - doi:10.1111/eip.12395
SP  - 7
EP  - 61
PY  - 2016
ER  - 

TY  - JOUR
TI  - Posters
JO  - Bipolar Disorders
JA  - Bipolar Disord
VL  - 18
IS  - S1
SN  - 9781118689745
UR  - https://doi.org/10.1111/bdi.12407
DO  - doi:10.1111/bdi.12407
SP  - 70
EP  - 194
PY  - 2016
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S2
SN  - 9781118689745
UR  - https://doi.org/10.1002/bjs.7050
DO  - doi:10.1002/bjs.7050
SP  - 1
EP  - 75
PY  - 2010
ER  - 

TY  - JOUR
TI  - Hapatopancreaticobiliary and Upper GI Surgery Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 82
IS  - s1
SN  - 9781118689745
UR  - https://doi.org/10.1111/j.1445-2197.2012.06058.x
DO  - doi:10.1111/j.1445-2197.2012.06058.x
SP  - 86
EP  - 102
PY  - 2012
ER  - 

TY  - JOUR
TI  - Index to Abstract Descriptors
JO  - Psychophysiology
JA  - Psychophysiology
VL  - 56
IS  - S1
SN  - 9781118689745
UR  - https://doi.org/10.1111/psyp.13504
DO  - doi:10.1111/psyp.13504
SP  - S136
EP  - S138
PY  - 2019
ER  - 

C7  - pp. i-xxix
TI  - Front Matter
SN  - 9783527345700
UR  - https://doi.org/10.1002/9783527819997.fmatter
DO  - doi:10.1002/9783527819997.fmatter
SP  - i-xxix
PY  - 2019
AB  - The prelims comprise: Half-Title Page Title Page Copyright Page Dedication Table of Contents Preface Acknowledgments List of Abbreviations
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 65
IS  - S1
SN  - 9783527345700
UR  - https://doi.org/10.1111/jgs.14915
DO  - doi:10.1111/jgs.14915
SP  - S1
EP  - S289
PY  - 2017
ER  - 

TY  - JOUR
AU  - He, Liang
AU  - Liu, Jianhua
AU  - Li, Shengxian
AU  - Feng, Xiangru
AU  - Wang, Chunxi
AU  - Zhuang, Xiuli
AU  - Ding, Jianxun
AU  - Chen, Xuesi
C7  - 1800122
TI  - Polymer Nanoplatforms at Work in Prostate Cancer Therapy
JO  - Advanced Therapeutics
JA  - Adv. Therap.
VL  - 2
IS  - 4
SN  - 9783527345700
UR  - https://doi.org/10.1002/adtp.201800122
DO  - doi:10.1002/adtp.201800122
SP  - 1800122
KW  - controlled drug delivery
KW  - polymer nanoplatform
KW  - prostate cancer
KW  - targetability
KW  - therapy
PY  - 2019
AB  - Abstract Prostate cancer (PCa) is the most common male urogenital malignancy worldwide. Surgery, endocrine therapy, radiotherapy, and chemotherapy are the main clinical management options for PCa. However, these three therapies each have limitations. For example, surgery is not suitable for the advanced PCa patients with extensive metastases, and radiotherapy causes serious side effects. Primary endocrine therapy promotes the progression of hormone-sensitive PCa into the castration-resistant prostate cancer. Therefore, considering these drawbacks, chemotherapy has become an effective and extensive treatment for PCa. Among the modern therapeutic strategies against advanced PCa, polymer-nanocarrier-incorporated formulations have gradually emerged due to their well-controlled release profiles and improved tumor targeting abilities. The drug delivery systems based on polymer nanoplatforms passively target tumors via the enhanced permeability and retention effect. Simultaneously, stimuli-responsive polymer nanoplatforms unload cargoes in response to certain stimuli in the tumor area. Furthermore, the active targeting ligand-conjugated polymer nanoformulations against PCa-specific markers have also achieved great success in PCa therapies. Herein, the advanced polymer nanoplatforms for PCa therapy are reviewed, while the future development of polymer nanoplatforms for PCa therapy is also predicted.
ER  - 

TY  - JOUR
AU  - Montes, Ramón
AU  - Guruceaga, Elisabet
AU  - González-Porras, José R.
AU  - Reverter, Joan C.
AU  - Marco, Pascual
AU  - Pina, Elena
AU  - Páramo, José A.
AU  - Hermida, José
AU  - Lecumberri, Ramón
AU  - Grupo de Trabajo de Patología Trombótica de la Sociedad Española de Trombosis y Hemostasia (SETH)
TI  - Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study
JO  - European Journal of Haematology
JA  - Eur J Haematol
VL  - 97
IS  - 2
SN  - 9783527345700
UR  - https://doi.org/10.1111/ejh.12692
DO  - doi:10.1111/ejh.12692
SP  - 128
EP  - 136
KW  - deep venous thrombosis
KW  - recurrence
KW  - gene expression profiling
KW  - ACSF2
PY  - 2016
AB  - Abstract Objective The aim of this study was to assess differences in the gene expression profile of peripheral blood cells between patients with early recurrent thrombosis vs. patients without recurrent events after withdrawal of anticoagulant therapy for a first episode of unprovoked deep vein thrombosis (uDVT), to identify novel predictors of recurrence. Methods In the discovery population (N = 32), a microarray RNA assay followed by RT-PCR confirmation were performed. In the validation population (N = 44) a multiple RT-PCR-based strategy was applied to assess genes differentially expressed in the discovery population. Results The sex-adjusted Linear Model for Microarray Data analysis showed 102 genes differentially expressed (P < 0.01) in the discovery population. Nineteen of them underwent further confirmation in the validation population. The gene encoding for Acyl-CoA Synthetase Family Member 2 (ACSF2) was underexpressed in recurrent DVT patients in both, the discovery (P = 0.007) and validation populations (P = 0.004). In the receiver operator characteristic (ROC) analysis, the areas under the curve of ACSF2 expression were 0.77 and 0.80, respectively. Conclusions For the first time an association between ACSF2 expression and the risk of recurrent DVT is suggested. Should this association be confirmed in larger prospective studies, ACSF2 could become useful for the selection of patients requiring extended anticoagulant therapy.
ER  - 

TY  - JOUR
AU  - Hi Cho, Yoon
AU  - Besser, Rachel EJ
AU  - Craig, Maria E
TI  - Highlights from the 37th Annual Meeting for ISPAD, Miami
JO  - Pediatric Diabetes
VL  - 13
IS  - 1
SN  - 9783527345700
UR  - https://doi.org/10.1111/j.1399-5448.2011.00850.x
DO  - doi:10.1111/j.1399-5448.2011.00850.x
SP  - 124
EP  - 131
KW  - adolescent
KW  - child
KW  - ISPAD
KW  - meeting
KW  - type 1 diabetes
PY  - 2012
AB  - Hi Cho Y, Besser REJ, Craig ME. Highlights from the 37th Annual Meeting for ISPAD, Miami. The 37th Annual Meeting for the International Society of Pediatric and Adolescent Diabetes was held in Miami Beach, Florida, USA. The meeting, titled ?Possibilities for Prevention and Diabetes and its Complications?, attracted over 1000 delegates from 52 countries. Fifty-six oral abstracts were presented, along with 294 posters, representing the diversity of research and clinical innovations in the field of pediatric and adolescent diabetes around the world. Abstracts to the Oral and Poster Sessions can be found in a recent supplement of Pediatric Diabetes (1). Here are some highlights from the plenary sessions, symposia, and oral presentations.
ER  - 

TY  - JOUR
TI  - Plenary Lecture
JO  - International Journal of Urology
JA  - Int J Urol
VL  - 21
IS  - S2
SN  - 9783527345700
UR  - https://doi.org/10.1111/iju.12708_1
DO  - doi:10.1111/iju.12708_1
SP  - A6
EP  - A65
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Presentation
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 26
IS  - S2
SN  - 9783527345700
UR  - https://doi.org/10.1111/iju.14063
DO  - doi:10.1111/iju.14063
SP  - 111
EP  - 233
PY  - 2019
ER  - 
